SCHEMBL6185704

SCHEMBL6185704

[Pb]Cc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3369428 0.74
Hydrochloric Acid SCHEMBL28411299 0.71
SCHEMBL9741303 0.69 ALDH1A1 (0.69)
Diphenylmethane SCHEMBL14763944 0.69 CALM1 (1.00)
Benzene SCHEMBL3440179 0.69 ALDH1A1 (0.69)
Diphenylmethane SCHEMBL3792579 0.69 CALM1 (1.00)
Diphenylmethane SCHEMBL1303 0.69 CALM1 (1.00)
Diphenylmethane SCHEMBL4361124 0.69 CALM1 (1.00)
SCHEMBL62125 0.69 ALDH1A1 (0.69)
SCHEMBL2867870 0.69 CALM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1159261-B1 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORP (US) 2005-11-02 EP disclosed
EP-1159261-A2 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORPORATION (US) 2001-12-05 EP disclosed
WO-2000046187-A2 ANTIZYME MODULATORS AND THEIR USE ORIDIGM CORPORATION (US) 2000-08-10 WO disclosed
EP-0576603-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA, CONTAINING A 5 ALPHA-REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO. INC. (US) 1994-01-05 EP disclosed